Valuation: Precipio, Inc.

Market Cap 4.15Cr 3.59Cr 3.37Cr 3.07Cr 5.75Cr 395.83Cr 5.86Cr 39Cr 15Cr 198.55Cr 16Cr 15Cr 660.88Cr P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 4.25Cr 3.67Cr 3.45Cr 3.14Cr 5.89Cr 405.39Cr 6Cr 40Cr 16Cr 203.34Cr 16Cr 16Cr 676.84Cr EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.35%
Yield 2024 *
-
Yield 2025 -
1 day+1.25%
1 week+0.17%
Current month+8.55%
1 month-2.08%
3 months-18.12%
6 months+0.47%
Current year+2.26%
1 week 21.48
Extreme 21.48
24.48
1 month 19.22
Extreme 19.22
25.78
Current year 19.22
Extreme 19.22
33.63
1 year 13.8
Extreme 13.8001
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+0.17%+64.45%+226.39% 4.15Cr
+1.02%+3.49%+20.90%-34.10% 1.7TCr
-2.98%+4.48%-7.86%+94.13% 181.54Cr
-5.24%-12.38%-47.19%-81.65% 103.48Cr
-0.44%-0.07%-30.41%+21.34% 99Cr
-0.05%+50.94%+72.97%-11.28% 78Cr
+0.95%+5.03%-36.88%-50.09% 69Cr
+3.92%+21.65%-39.26%-41.27% 62Cr
-0.99%+20.60%+41.99%+38.83% 42Cr
+5.89%+11.30%-41.31%-39.98% 42Cr
Average +0.33%+8.72%-0.26%+12.23% 238.34Cr
Weighted average by Cap. +0.47%+4.13%+11.45%-22.38%

Financials

2024 2025
Net sales 1.85Cr 1.6Cr 1.51Cr 1.37Cr 2.57Cr 176.82Cr 2.62Cr 18Cr 6.9Cr 89Cr 6.96Cr 6.81Cr 295.22Cr 2.4Cr 2.08Cr 1.96Cr 1.78Cr 3.34Cr 229.46Cr 3.4Cr 23Cr 8.95Cr 115.1Cr 9.03Cr 8.83Cr 383.11Cr
Net income -42.9L -37.09L -34.88L -31.71L -59.51L -41Cr -60.58L -4.08Cr -1.6Cr -21Cr -1.61Cr -1.58Cr -68Cr -4L -3L -3L -3L -5L -3.46Cr -5L -34.54L -13.51L -1.74Cr -13.63L -13.33L -5.78Cr
Net Debt -1L -1L -1L -1L -2L -1.3Cr -2L -12.94L -5L -65.09L -5L -5L -2.17Cr 10.02L 9L 8L 7L 13.9L 9.56Cr 14.15L 95.35L 37.3L 4.8Cr 37.62L 36.8L 16Cr
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
14/26/14 $23.50 +1.25% 75,806
13/26/13 $23.21 +2.97% 4,11,282
12/26/12 $22.54 +0.85% 86,459
11/26/11 $22.35 -1.11% 61,485
10/26/10 $22.60 -5.72% 2,46,845
  1. Stock Market
  2. Stocks
  3. PRPO Stock